ACM
IDXX icon

Anfield Capital Management’s Idexx Laboratories IDXX Stock Holding History

Anfield Capital Management’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-10
Closed -$4.2K – 534
2025
Q1 		$4.2K Hold
10
– – ﹤0.01% 345
2024
Q4 		$4.13K Hold
10
– – ﹤0.01% 329
2024
Q3 		$5.05K Hold
10
– – ﹤0.01% 316
2024
Q2 		$4.87K Buy
+10
New +$5.02K ﹤0.01% 266

Other funds holding IDXX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fundsmith LLP
Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Polen Capital Management
Polen Capital Management Boca Raton, Florida $14.5B AUM 5.7% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Anfield Capital Management's IDXX Position: Q2 2025 in Review

Anfield Capital Management sold out of Idexx Laboratories (IDXX) in Q2 2025, closing a stake of 10 shares — an estimated $4.2K sold.

Anfield Capital Management first reported a position in IDXX in Q2 2024 and held it in 4 quarters. The position peaked at $5.05K in Q3 2024. 1,234 funds tracked by Wall St. Rank hold IDXX as of Q2 2025.

  • Anfield Capital Management reported no remaining Idexx Laboratories position as of Q2 2025 after selling out during the quarter.
  • Anfield Capital Management sold 10 Idexx Laboratories shares in Q2 2025, an estimated $4.2K.
  • Anfield Capital Management first reported a position in Idexx Laboratories in Q2 2024 and held it in 4 quarters.
  • Anfield Capital Management's Idexx Laboratories position peaked at $5.05K in Q3 2024.
  • 1,234 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2025.

Based on Anfield Capital Management's 13F filing for Q2 2025, filed 11 Aug 2025.